Inhibitor Therapeutics (INTI) SEC Filings & 10K Form $0.07 0.00 (0.00%) As of 02/21/2025 Add Compare Share Share SEC Filings Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Recent Inhibitor Therapeutics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView02/19/20258:28 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)MCNULTY JAMES A (Reporting)Form 5Annual statement of changes in beneficial ownership of securities 02/19/20258:27 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)Yanez Michelle (Reporting)Form 5Annual statement of changes in beneficial ownership of securities 11/12/20245:27 AMInhibitor Therapeutics, Inc. (Filer)Inhibitor Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 08/06/20248:30 AMInhibitor Therapeutics, Inc. (Filer)Inhibitor Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 05/16/202412:34 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)Jerman Michael Allen (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/16/202412:34 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)OSMAN RONALD E (Reporting)Ronald E Osman Irrevocable Trust III (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/16/202412:34 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)SEARS SAMUEL P JR (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/16/202412:34 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)MCNULTY JAMES A (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/16/202412:34 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)Yanez Michelle (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/13/20248:00 AMInhibitor Therapeutics, Inc. (Filer)Inhibitor Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies ELYM 10Q Form ICCC 10Q Form DTIL 10Q Form MDCX 10Q Form PVCT 10Q Form ATRA 10Q Form FBLG 10Q Form OVID 10Q Form GBIO 10Q Form RAPT 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (OTCMKTS:INTI) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredCritical ‘Buy Now’ Alert on My Favorite Stock!My absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibitor Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibitor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INTI Stock Alerts